D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
The striatum, which is the major component of the basal ganglia in the brain, is regulated in part by dopaminergic input from the substantia nigra. Severe movement disorders result from the loss of striatal dopamine in patients with Parkinson's disease. Rats with lesions of the nigrostriatal dopamine pathway caused by 6-hydroxydopamine (6-OHDA) serve as a model for Parkinson's disease and show alterations in gene expression in the two major output systems of the striatum to the globus pallidus and substantia nigra. Striatopallidal neurons show a 6-OHDA-induced elevation in their specific expression of messenger RNAs (mRNAs) encoding the D 2 dopamine receptor and enkephalin, which is reversed by subsequent continuous treatment with the D 2 agonist quinpirole. Conversely, striatonigral neurons show a 6-OHDA-induced reduction in their specific expression of mRNAs encoding the D 1 dopamine receptor and substance P, which is reversed by subsequent daily injections of the D 1 agonist SKF-38393. This treatment also increases dynorphin mRNA in striatonigral neurons. Thus, the differential effects of dopamine on striatonigral and striatopallidal neurons are mediated by their specific expression of D 1 and D 2 dopamine receptor subtypes, respectively.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The NAc is composed of a vast array of transcriptionally distinct neuronal subtypes, where medium spiny neurons (MSNs) make up the majority (>95%) of the cells (16).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
In the citing paper
“These neurons are defined by their transcriptional profiles, including dopamine receptor 1 (D1) vs. dopamine receptor 2 (D2) expression, substance P and enkephalin, and other enriched genes (16–18).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
Citations
Cites
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,725
DOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION
HORNYKIEWICZ, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,442
Fluoro-gold: a new fluorescent retrograde axonal tracer with numerous unique properties
Schmued, L. C., & Fallon, J. H. (1986) · Brain Research · doi:10.1016/0006-8993(86)91199-6 · Cited by 886
Freund, T. F., Powell, J. F., & Smith, A. D. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90294-x · Cited by 865
Hikosaka, O., & Wurtz, R. H. (1983) · Journal of Neurophysiology · doi:10.1152/jn.1983.49.5.1285 · Cited by 808
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Gerfen, C. R., & Scott Young, W. (1988) · Brain Research · doi:10.1016/0006-8993(88)91217-6 · Cited by 658
Self-citationMultiple D2 dopamine receptors produced by alternative RNA splicing
Monsma, F. J., McVittie, L. D., Gerfen, C. R., Mahan, L. C., & Sibley, D. R. (1989) · Nature · doi:10.1038/342926a0 · Cited by 641
Self-citationProjection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin
Kawaguchi, Y., Wilson, C., & Emson, P. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-10-03421.1990 · Cited by 565
Research works printed but not linked: 1
- HONG, J.S., ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY 24: 223 (1980).
Cited by
Items 101–200 of 1,013
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
Bézard, E., Ferry, S., Mach, U., Stark, H., Leriche, L., Boraud, T., Gross, C., & Sokoloff, P. (2003) · Nature Medicine · doi:10.1038/nm875 · Cited by 383
Lobo, M. K., & Nestler, E. J. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00041 · Cited by 381
Francis, T. C., Chandra, R., Friend, D. M., Finkel, E., Dayrit, G., Miranda, J., Brooks, J. M., Iñiguez, S. D., O’Donnell, P., Kravitz, A., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.021 · Cited by 379
Basal ganglia orient eyes to reward
Hikosaka, O., Nakamura, K., & Nakahara, H. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00458.2005 · Cited by 377
“In fact, D1 and D2 receptors are expressed preferentially in direct-pathway neurons and indirect-pathway neurons, respectively (Gerfen et al. 1990; Surmeier et al. 1996).”
BackgroundMechanism of Deep Brain Stimulation: Inhibition, Excitation, or Disruption?
Chiken, S., & Nambu, A. (2016) · The Neuroscientist · doi:10.1177/1073858415581986 · Cited by 375
Gerfen, C. R., Miyachi, S., Paletzki, R., & Brown, P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-05042.2002 · Cited by 373
Self-citationLevodopa in the treatment of Parkinson's disease: Current controversies
Olanow, C. W., Agid, Y., Mizuno, Y., Albanese, A., Bonucelli, U., Damier, P., De Yebenes, J., Gershanik, O., Guttman, M., Grandas, F., et al. (2004) · Movement Disorders · doi:10.1002/mds.20243 · Cited by 370
A Physiologically Plausible Model of Action Selection and Oscillatory Activity in the Basal Ganglia
Humphries, M. D., Stewart, R. D., & Gurney, K. N. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3486-06.2006 · Cited by 370
Oxytocin, motivation and the role of dopamine
Love, T. M. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.06.011 · Cited by 369
“D1 receptors are enriched along the striatonigral ‘direct’ pathway whereas D2 receptors are observed along the striatopallidal ‘indirect’ pathway (Gerfen et al. , 1990).”
Cole, R. L., Konradi, C., Douglass, J., & Hyman, S. E. (1995) · Neuron · doi:10.1016/0896-6273(95)90225-2 · Cited by 365
Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior
Steiner, H., & Gerfen, C. R. (1998) · Experimental Brain Research · doi:10.1007/s002210050545 · Cited by 365
Self-citationAdenosine-dopamine interactions in the brain
Ferré, S., Fuxe, K., von Euler, G., Johansson, B., & Fredholm, B. B. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90291-9 · Cited by 364
The comorbidity of insomnia, chronic pain, and depression: Dopamine as a putative mechanism
Finan, P. H., & Smith, M. T. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.03.003 · Cited by 363
Lee, K.-W., Kim, Y., Kim, A. M., Helmin, K., Nairn, A. C., & Greengard, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511244103 · Cited by 362
Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors
Bateup, H. S., Santini, E., Shen, W., Birnbaum, S., Valjent, E., Surmeier, D. J., Fisone, G., Nestler, E. J., & Greengard, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009874107 · Cited by 360
The basal ganglia in Parkinson's disease: Current concepts and unexplained observations
Obeso, J. A., Marin, C., Rodriguez-Oroz, C., Blesa, J., Benitez-Temiño, B., Mena-Segovia, J., Rodríguez, M., & Olanow, C. W. (2009) · Annals of Neurology · doi:10.1002/ana.21481 · Cited by 359
Basal ganglia dysfunction in Tourette’s syndrome: a new hypothesis
Mink, J. W. (2001) · Pediatric Neurology · doi:10.1016/s0887-8994(01)00262-4 · Cited by 357
“Some evidence suggests that D1 receptors are preferentially located on cells that project to GPi or SNpr and that D2 receptors are located on cells that project to GPe [34].”
BackgroundInfluentialThe Basal Ganglia Over 500 Million Years
Grillner, S., & Robertson, B. (2016) · Current Biology · doi:10.1016/j.cub.2016.06.041 · Cited by 357
A Complex Program of Striatal Gene Expression Induced by Dopaminergic Stimulation
Berke, J. D., Paletzki, R. F., Aronson, G. J., Hyman, S. E., & Gerfen, C. R. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05301.1998 · Cited by 356
Self-citationDopamine and N-Methyl-D- Aspartate Receptor Interactions in the Neostriatum
Cepeda, C., & Levine, M. S. (1998) · Developmental Neuroscience · doi:10.1159/000017294 · Cited by 351
Stocco, A., Lebiere, C., & Anderson, J. R. (2010) · Psychological Review · doi:10.1037/a0019077 · Cited by 350
Diametric neural ensemble dynamics in parkinsonian and dyskinetic states
Parker, J. G., Marshall, J. D., Ahanonu, B., Wu, Y.-W., Kim, T. H., Grewe, B. F., Zhang, Y., Li, J. Z., Ding, J. B., Ehlers, M. D., et al. (2018) · Nature · doi:10.1038/s41586-018-0090-6 · Cited by 349
Spatially Compact Neural Clusters in the Dorsal Striatum Encode Locomotion Relevant Information
Barbera, G., Liang, B., Zhang, L., Gerfen, C. R., Culurciello, E., Chen, R., Li, Y., & Lin, D.-T. (2016) · Neuron · doi:10.1016/j.neuron.2016.08.037 · Cited by 347
Self-citationHassani, O.-K., Mouroux, M., & Féger, J. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00535-8 · Cited by 345
Induction of dopamine D 3 receptor expression as a mechanism of behavioral sensitization to levodopa
Bordet, R., Ridray, S., Carboni, S., Diaz, J., Sokoloff, P., & Schwartz, J.-C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3363 · Cited by 345
The two-century journey of Parkinson disease research
Przedborski, S. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.25 · Cited by 345
Schwarting, R. K. W., & Huston, J. P. (1996) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00015-9 · Cited by 344
Altered striatal function in a mutant mouse lacking D1A dopamine receptors.
Drago, J., Gerfen, C. R., Lachowicz, J. E., Steiner, H., Hollon, T. R., Love, P. E., Ooi, G. T., Grinberg, A., Lee, E. J., & Huang, S. P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12564 · Cited by 343
Self-citationMolecular effects of dopamine on striatal-projection pathways
Gerfen, C. R. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00019-7 · Cited by 341
Self-citationOpponent and bidirectional control of movement velocity in the basal ganglia
Yttri, E. A., & Dudman, J. T. (2016) · Nature · doi:10.1038/nature17639 · Cited by 338
Reassessing Models of Basal Ganglia Function and Dysfunction
Nelson, A. B., & Kreitzer, A. C. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-013916 · Cited by 337
Deep Brain Stimulation for Neurologic and Neuropsychiatric Disorders
Wichmann, T., & DeLong, M. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.022 · Cited by 331
Nguyen, T. V., Kosofsky, B. E., Birnbaum, R., Cohen, B. M., & Hyman, S. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4270 · Cited by 331
Basal ganglia intrinsic circuits and their role in behavior
Mink, J. W., & Thach, W. T. (1993) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(93)90167-w · Cited by 328
Robertson, G. S., Vincent, S. R., & Fibiger, H. C. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90096-k · Cited by 328
Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes
Bernard, V, Normand, E., & Bloch, B. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-09-03591.1992 · Cited by 327
Self, D. W., Genova, L. M., Hope, B. T., Barnhart, W. J., Spencer, J. J., & Nestler, E. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-05-01848.1998 · Cited by 325
Murray, A. M., Ryoo, H. L., Gurevich, E., & Joyce, J. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11271 · Cited by 325
Raymond, L. A., André, V. M., Cepeda, C., Gladding, C. M., Milnerwood, A. J., & Levine, M. S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.052 · Cited by 325
The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease
Huot, P., Johnston, T. H., Koprich, J. B., Fox, S. H., & Brotchie, J. M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005678 · Cited by 324
Gaspar, P., Bloch, B., & Le Moine, C. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01092.x · Cited by 323
Anatomy of the dopamine system in the basal ganglia
Smith, Y., & Kieval, J. Z. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00023-9 · Cited by 323
Gomeza, J., Zhang, L., Kostenis, E., Felder, C., Bymaster, F., Brodkin, J., Shannon, H., Xia, B., Deng, C.-X., & Wess, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10483 · Cited by 322
The Neuropathology of Huntington’s Disease
Waldvogel, H. J., Kim, E. H., Tippett, L. J., Vonsattel, J.-P. G., & Faull, R. L. (2014) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2014_354 · Cited by 317
The role of the striatum in social behavior
Báez-Mendoza, R., & Schultz, W. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00233 · Cited by 312
“MSN that express D2 receptors mostly target the external segment of the globus pallidus (GPe) and form the indirect pathway (Parent et al., 1984; Gerfen et al., 1990; Kawaguchi et al., 1990; Chuhma et al., 2011).”
BackgroundLu, X.-Y., Behnam Ghasemzadeh, M., & Kalivas, P. W. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00327-8 · Cited by 312
Pathophysiology of Parkinson's disease: From clinical neurology to basic neuroscience and back
Bergman, H., & Deuschl, G. (2002) · Movement Disorders · doi:10.1002/mds.10140 · Cited by 310
Adenosine A2 receptor-mediated excitatory actions on the nervous system
SEBASTIAO, A. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00035-6 · Cited by 304
di Marzo, V., Hill, M. P., Bisogno, T., Crossman, A. R., & Brotchie, J. M. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.10.1432 · Cited by 303
Hohmann, A. G., & Herkenham, M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00524-7 · Cited by 301
Spatial and temporal scales of dopamine transmission
Liu, C., Goel, P., & Kaeser, P. S. (2021) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00455-7 · Cited by 301
Paul, M., Graybiel, A., David, J., & Robertson, H. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-10-03729.1992 · Cited by 299
D2R striatopallidal neurons inhibit both locomotor and drug reward processes
Durieux, P. F., Bearzatto, B., Guiducci, S., Buch, T., Waisman, A., Zoli, M., Schiffmann, S. N., & de Kerchove d'Exaerde, A. (2009) · Nature Neuroscience · doi:10.1038/nn.2286 · Cited by 297
Levodopa‐induced dyskinesias improved by a glutamate antagonist in parkinsonia monkeys
Papa, S. M., & Chase, T. N. (1996) · Annals of Neurology · doi:10.1002/ana.410390505 · Cited by 292
Self-citationReward behaviour is regulated by the strength of hippocampus–nucleus accumbens synapses
LeGates, T. A., Kvarta, M. D., Tooley, J. R., Francis, T. C., Lobo, M. K., Creed, M. C., & Thompson, S. M. (2018) · Nature · doi:10.1038/s41586-018-0740-8 · Cited by 290
BURNS, L., ROBBINS, T., & EVERITT, B. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90113-5 · Cited by 289
What, If, and When to Move: Basal Ganglia Circuits and Self-Paced Action Initiation
Klaus, A., Alves da Silva, J., & Costa, R. M. (2019) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-072116-031033 · Cited by 284
Gerfen, C., Keefe, K., & Gauda, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-12-08167.1995 · Cited by 283
“Enkephalin has been demonstrated to be a reliable marker of striatopallidal neurons (Gerfen and Young, 1988), which have also been demonstrated to express 02 receptor mRNA (Gerfen et al., 1990).”
BackgroundInfluentialSelf-citation(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.9.1248 · Cited by 280
Prominence of the dopamine D2 short isoform in dopaminergic pathways
Khan, Z. U., Mrzljak, L., Gutierrez, A., de la Calle, A., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7731 · Cited by 278
Matamales, M., Bertran-Gonzalez, J., Salomon, L., Degos, B., Deniau, J.-M., Valjent, E., Hervé, D., & Girault, J.-A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004770 · Cited by 278
Lei, W., Jiao, Y., Del Mar, N., & Reiner, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1990-04.2004 · Cited by 277
Levivier, M., Przedborski, S., Bencsics, C., & Kang, U. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-12-07810.1995 · Cited by 274
Functional Connectome of the Striatal Medium Spiny Neuron
Chuhma, N., Tanaka, K. F., Hen, R., & Rayport, S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3833-10.2011 · Cited by 271
Striatal Circuits as a Common Node for Autism Pathophysiology
Fuccillo, M. V. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00027 · Cited by 269
Striatal Local Circuitry: A New Framework for Lateral Inhibition
Burke, D. A., Rotstein, H. G., & Alvarez, V. A. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.019 · Cited by 268
Neostriatal cell subtypes and their functional roles
Kawaguchi, Y. (1997) · Neuroscience Research · doi:10.1016/s0168-0102(96)01134-0 · Cited by 266
Cooper, S., Robison, A. J., & Mazei-Robison, M. S. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0525-z · Cited by 265
Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia
Cenci, M. A. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.005 · Cited by 265
Herve, D., Levi-Strauss, M., Marey-Semper, I., Verney, C., Tassin, J., Glowinski, J., & Girault, J. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-05-02237.1993 · Cited by 264
LIANA+ Provides an All-in-One Framework for Cell–Cell Communication Inference
Dimitrov, D., Schäfer, P. S. L., Farr, E., Rodriguez-Mier, P., Lobentanzer, S., Badia-i-Mompel, P., Dugourd, A., Tanevski, J., Ramirez Flores, R. O., & Saez-Rodriguez, J. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01469-w · Cited by 263
“Our analysis additionally hinted at an anticipated asymmetry following uni-hemispheric lesion 38 : while the interaction between D2R and dopamine was present in the intact hemisphere (Fig.”
Subthalamotomy in parkinsonian monkeys Behavioural and biochemical analysis
Guridi, J., Herrero, M. T., Luquin, M. R., Guillén, J., Ruberg, M., Laguna, J., Vila, M., Javoy-Agid, F., Agid, Y., Hirsch, E., et al. (1996) · Brain · doi:10.1093/brain/119.5.1717 · Cited by 263
Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
Richardson, P. J., Kase, H., & Jenner, P. G. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01096-1 · Cited by 263
Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein
Ho, M. (1994) · Cell · doi:10.1016/0092-8674(94)90136-8 · Cited by 260
Zhang, M., & Kelley, A. E. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00198-6 · Cited by 260
Acetylcholine–Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders
Lester, D. B., Rogers, T. D., & Blaha, C. D. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00142.x · Cited by 259
Dopamine activation of the arachidonic acid cascade as a basis for D1D2 receptor synergism
Piomelli, D., Pilon, C., Giros, B., Sokolofff, P., Martres, M.-P., & Schwartz, J.-C. (1991) · Nature · doi:10.1038/353164a0 · Cited by 258
The Spatiotemporal Organization of the Striatum Encodes Action Space
Klaus, A., Martins, G. J., Paixao, V. B., Zhou, P., Paninski, L., & Costa, R. M. (2017) · Neuron · doi:10.1016/j.neuron.2017.08.015 · Cited by 258
Molecular neurobiology of dopaminergic receptors
Sibley, D. R., Monsma, F. J., & Shen, Y. (1993) · International review of neurobiology · doi:10.1016/s0074-7742(08)60573-5 · Cited by 255
Self-citationPathophysiology of Parkinson's Disease: The MPTP Primate Model of the Human Disorder
WICHMANN, T., & DeLONG, M. R. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07477.x · Cited by 255
Opiate-like effects of sugar on gene expression in reward areas of the rat brain
Spangler, R., Wittkowski, K. M., Goddard, N. L., Avena, N. M., Hoebel, B. G., & Leibowitz, S. F. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.02.013 · Cited by 255
Timing is not everything: neuromodulation opens the STDP gate
Pawlak, V. (2010) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2010.00146 · Cited by 255
Distinct Roles of D1and D5Dopamine Receptors in Motor Activity and Striatal Synaptic Plasticity
Centonze, D., Grande, C., Saulle, E., Martín, A. B., Gubellini, P., Pavón, N., Pisani, A., Bernardi, G., Moratalla, R., & Calabresi, P. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08506.2003 · Cited by 251
Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons
Schiffmann, S., & Vanderhaeghen, J. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-03-01080.1993 · Cited by 251
The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain
Ferre, S., O'Connor, W., Fuxe, K., & Ungerstedt, U. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-12-05402.1993 · Cited by 251
Gerfen, C. R., & Wilson, C. J. (1996) · Handbook of Chemical Neuroanatomy · doi:10.1016/s0924-8196(96)80004-2 · Cited by 250
Self-citationThe basal ganglia: An overview of circuits and function
Utter, A. A., & Basso, M. A. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.11.003 · Cited by 249
Neurotensin and Dopamine Interactions
Binder, E. B., Kinkead, B., Owens, M. J., & Nemeroff, C. B. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01509-6 · Cited by 248
Hood, S., Cassidy, P., Cossette, M.-P., Weigl, Y., Verwey, M., Robinson, B., Stewart, J., & Amir, S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2128-10.2010 · Cited by 246
“After a 6-OHDA lesion, however, the expression of D2 DA receptors on cell bodies is lost through destruction of DA fibers, whereas postsynaptic expression of D2 DA receptors in medium spiny neurons is upregulated (Gerfen et al., 1990).”
BackgroundInfluentialBDNF signaling and survival of striatal neurons
Baydyuk, M., & Xu, B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00254 · Cited by 245
Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state
Galvan, A., Devergnas, A., & Wichmann, T. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00005 · Cited by 244
Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease
Xu, K., Bastia, E., & Schwarzschild, M. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.007 · Cited by 244
Dopamine Receptors and Neurodegeneration
Claudia, R., Israel, C., & Benjamín, F. (2015) · Aging and disease · doi:10.14336/ad.2015.0330 · Cited by 241
Frontal-subcortical circuits: the anatomic basis of executive, social and motivated behaviors
Masterman, D. L., & Cummings, J. L. (1997) · Journal of Psychopharmacology · doi:10.1177/026988119701100203 · Cited by 241
Genetic Dissection of Behavioural and Autonomic Effects of Δ9-Tetrahydrocannabinol in Mice
Monory, K., Blaudzun, H., Massa, F., Kaiser, N., Lemberger, T., Schütz, G., Wotjak, C. T., Lutz, B., & Marsicano, G. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050269 · Cited by 238
Are neostriatal dopamine receptors co-localized?
Surmeier, D. J., Reiner, A., Levine, M. S., & Ariano, M. A. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90103-s · Cited by 237
Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology
Marconi, R., Lefebvre‐Caparros, D., Bonnet, A., Vidailhet, M., Dubois, B., & Agid, Y. (1994) · Movement Disorders · doi:10.1002/mds.870090103 · Cited by 237
Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum
Steiner, H., & Gerfen, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-12-05066.1993 · Cited by 235
Self-citationLevodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis
Graybiel, A. M., Canales, J. J., & Capper-Loup, C. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00027-6 · Cited by 234
Cell type–specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs
Bateup, H. S., Svenningsson, P., Kuroiwa, M., Gong, S., Nishi, A., Heintz, N., & Greengard, P. (2008) · Nature Neuroscience · doi:10.1038/nn.2153 · Cited by 233
“Striatonigral neurons project via the direct pathway to the output nuclei of the basal ganglia and preferentially express dopamine type 1 receptors (D1Rs”
Background
Metadata
- Authors
- Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R.
- Affiliations
- National Institutes of Health (US)
- Venue
- Science
- Published
- 1990-12-07
- Volume
- 250
- Issue
- 4986
- Pages
- 1429-1432
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1991603311
- Cited by
- 2,967
- References
- 38
- Citations by year
- 2026: 54 · 2025: 60 · 2024: 73 · 2023: 64 · 2022: 89 · 2021: 84 · 2020: 79 · 2019: 85 · 2018: 90 · 2017: 79 · 2016: 102 · 2015: 106 · 2014: 95 · 2013: 79 · 2012: 97
- FWCI
- 27.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- dopamine D1 receptor, dopamine D2 receptor, striatonigral neurons, striatopallidal neurons, gene expression, 6-hydroxydopamine lesion, Parkinson's disease model, substantia nigra, globus pallidus, enkephalin, substance P, dynorphin, quinpirole, SKF 38393, basal ganglia, dopamine agonists
- MeSH terms
- Animals, Cerebral Cortex, Corpus Striatum, Ergolines, Gene Expression Regulation, Globus Pallidus, Hydroxydopamines, Models, Neurological, Neurons, Receptors, Dopamine, RNA, Messenger, Substantia Nigra, Thalamus, Oligonucleotide Probes, 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine, Oxidopamine, Receptors, Dopamine D1, Receptors, Dopamine D2, Quinpirole, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.